Shusen Wang
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 72
- HER2/EGFR in Cancer Research 39
- Cancer Treatment and Pharmacology 24
- Lung Cancer Research Studies 9
- Peptidase Inhibition and Analysis 6
-
- Advanced Breast Cancer Therapies 31
- Brain Metastases and Treatment 8
- Co-authors
- Roujun Peng (15 shared papers)Zhongyu Yuan (40 shared papers)Zhongsheng Tong (18 shared papers)Tao Qin (9 shared papers)Cong Xue (11 shared papers)Rongzhen Luo (1 shared paper)Zefei Jiang (10 shared papers)Yanxia Shi (29 shared papers)
- Journals
- Journal of Clinical Oncology (26 papers)Cancer Research (5 papers)Breast Cancer Research and Treatment (5 papers)The Oncologist (5 papers)BMC Cancer (5 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Shusen Wang
122 papers receiving 2.7k citations
Shusen Wang's Hit Papers
Peers
Comparison fields: 5 of 114
- Oncology 1.1k
- Cancer Research 453
- Pulmonary and Respiratory Medicine 660
- Genetics 105
- Immunology 195
Countries citing papers authored by Shusen Wang
This map shows the geographic impact of Shusen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shusen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shusen Wang more than expected).
Fields of papers citing papers by Shusen Wang
This network shows the impact of papers produced by Shusen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shusen Wang. The network helps show where Shusen Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Shusen Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 135 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 256 | |
| 2 | 2019 | 253 | |
| 3 | 2014 | 176 | |
| 4 | 2014 | 163 | |
| 5 | 2011 | 136 | |
| 6 | 2013 | 100 | |
| 7 | 2011 | 76 | |
| 8 | 2021 | 64 | |
| 9 | 2015 | 63 | |
| 10 | 2006 | 60 | |
| 11 | 2012 | 53 | |
| 12 | 2018 | 53 | |
| 13 | 2022 | 51 | |
| 14 | 2022 | 49 | |
| 15 | 2008 | 40 | |
| 16 | 2019 | 37 | |
| 17 | 2019 | 36 | |
| 18 | 2017 | 35 | |
| 19 | 2014 | 34 | |
| 20 | 2019 | 33 |
About Shusen Wang
Shusen Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 135 papers that have together received 2.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (39 papers), Advanced Breast Cancer Therapies (31 papers), Cancer Treatment and Pharmacology (24 papers), Breast Cancer Treatment Studies (16 papers), Lung Cancer Research Studies (9 papers), Brain Metastases and Treatment (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Peptidase Inhibition and Analysis (6 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (453 citations), Pulmonary and Respiratory Medicine (660 citations), Genetics (105 citations) and Immunology (195 citations). Shusen Wang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Roujun Peng, Zhongyu Yuan, Zhongsheng Tong, Tao Qin, Cong Xue, Rongzhen Luo, Zefei Jiang, Yanxia Shi, Wěi Li and Hao Yu. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Breast Cancer Research and Treatment, The Oncologist and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.